Page last updated: 2024-10-26

etanidazole and Carcinoma, Small Cell

etanidazole has been researched along with Carcinoma, Small Cell in 2 studies

Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research Excerpts

ExcerptRelevanceReference
"Etanidazole was administered intravenously at a dose of 2 g/m2 three times per week for a total of 30 g/m2 during the course of thoracic radiation that delivered 50."2.69Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study. ( Belch, A; Hanson, J; Hewitt, J; Kinney, B; Palmer, M; Urtasun, RC, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komar, G1
Seppänen, M1
Eskola, O1
Lindholm, P1
Grönroos, TJ1
Forsback, S1
Sipilä, H1
Evans, SM1
Solin, O1
Minn, H1
Urtasun, RC1
Palmer, M1
Kinney, B1
Belch, A1
Hewitt, J1
Hanson, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer[NCT01881451]5 participants (Actual)Observational2013-08-31Terminated (stopped due to Due to slow accrual and access to the study drug.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for etanidazole and Carcinoma, Small Cell

ArticleYear
Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    International journal of radiation oncology, biology, physics, 1998, Jan-15, Volume: 40, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality

1998

Other Studies

1 other study available for etanidazole and Carcinoma, Small Cell

ArticleYear
18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:12

    Topics: Adult; Aged; Carcinoma, Small Cell; Cell Hypoxia; Etanidazole; Female; Fluorine Radioisotopes; Head

2008